Ronald Van Der Geest
Chief Development Officer
Molecular Biology
Treeway NL
Netherlands
Biography
Ronald is Treeway’s CDO since 2013. He holds broad drug development experience. He led various development programs and supervised project leaders for a broad range of disease indications in the small molecule and biologics arena. As an example, he led the development of Prezista™ for Tibotec/Johnson&Johnson and more recently of Glybera™ for uniQure, the 1st approved gene therapy product in the EU.
Research Interest
Molecular Biology
